Endurance exercise training in myostatin null mice

Muscle and Nerve

Volumn 42, Issue 3, 2010, Pages 355-362

  Savage, Kathleen J ^a   McPherron, Alexandra C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Endurance training; Exercise capacity; Glycolytic fiber type; Hypertrophy; Myostatin; Skeletal muscle

Indexed keywords

CITRATE SYNTHASE; MYOSTATIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDURANCE TRAINING; ENZYME ACTIVITY; EXERCISE; GENOTYPE; HISTOLOGY; MALE; MOUSE; MUSCLE EXERCISE; MUSCLE INJURY; MUSCLE MASS; NONHUMAN; OXIDATION; PLASTICITY; PRIORITY JOURNAL; SKELETAL MUSCLE; TREADMILL EXERCISE; TRICEPS BRACHII MUSCLE;

ANIMALS; BODY WEIGHT; CITRATE (SI)-SYNTHASE; COLORING AGENTS; EVANS BLUE; GLYCOLYSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOSTATIN; ORGAN SIZE; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SUCCINATE DEHYDROGENASE;

EID: 77956032273     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21688     Document Type: Article

References (52)

1. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 2004;20:61-86.
2. Patel K, Amthor H. The function of myostatin and strategies of myostatin blockade - new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscul Disord 2005;15:117-126. (Pubitemid 40202738)
3. Walsh FS, Celeste AJ. Myostatin: a modulator of skeletal-muscle stem cells. Biochem Soc Trans 2005;33:1513-1517.
4. Amthor H, Otto A, Vulin A, Rochat A, Dumonceaux J, Garcia L, et al. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Natl Acad Sci USA 2009; 106:7479-7484.
5. Girgenrath S, Song K, Whittemore LA. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve 2005; 31:34-40. (Pubitemid 40053924)
6. McPherron AC, Huynh TV, Lee SJ. Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol 2009;9:24.
7. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-b superfamily member. Nature 1997;387: 83-90.
8. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol 2006;101:898-905.
9. Lee SJ. Sprinting without myostatin: a genetic determinant of athletic prowess. Trends Genet 2007;23:475-477.
10. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009;4:e4937.
11. Hamrick MW, Pennington C, Webb CN, Isales CM. Resistance to body fat gain in 'double-muscled' mice fed a high-fat diet. Int J Obes (Lond) 2006;30:868-870.
12. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 2002;291:701-706. (Pubitemid 34687403)
13. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002;109:595-601. (Pubitemid 34204838)
14. Wilkes JJ, Lloyd DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009;58: 1133-1143.
15. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci USA 2005;102: 18117-18122. (Pubitemid 41798511)
16. Tang L, Yan Z, Wan Y, Han W, Zhang Y. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice. Muscle Nerve 2007;36:342-348. (Pubitemid 47326013)
17. Welle S, Burgess K, Mehta S. Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice. Am J Physiol Endocrinol Metab 2009;296:E567-572.
18. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003;300: 965-971. (Pubitemid 36262030)
19. Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA 2003; 100:15842-15846. (Pubitemid 38021077)
20. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002;420:418-421. (Pubitemid 35415652)
21. Bogdanovich S, McNally EM, Khurana TS. Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C. Muscle Nerve 2008;37:308-316. (Pubitemid 351304790)
22. Bogdanovich S, Perkins KJ, Krag TO, Whittemore LA, Khurana TS. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 2005;19:543-549. (Pubitemid 40471245)
23. Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C, et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 2008;105:4318-4322. (Pubitemid 351754378)
24. Morrison BM, Lachey JL, Warsing LC, Ting BL, Pullen AE, Underwood KW, et al. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 2009;217:258-268.
25. Parsons SA, Millay DP, Sargent MA, McNally EM, Molkentin JD. Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am J Pathol 2006;168: 1975-1985.
26. Qiao C, Li J, Jiang J, Zhu X, Wang B, Xiao X. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 2008;19:241-254.
27. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 2008;63:561-571.
28. Krivickas LS, Walsh R, Amato AA. Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029. Muscle Nerve 2009;39:3-9.
29. Fedoruk MN, Rupert JL. Myostatin inhibition: a potential performance enhancement strategy? Scand J Med Sci Sports 2008;18: 123-131.
30. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996;76: 371-423. (Pubitemid 26163713)
31. Baar K. Training for endurance and strength: lessons from cell signaling. Med Sci Sports Exerc 2006;38:1939-1944. (Pubitemid 44707798)
32. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 2007;104: 1835-1840. (Pubitemid 46239865)
33. Wagner KR, McPherron AC, Winik N, Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002;52:832-836. (Pubitemid 35403195)
34. LeBrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG, Loria PM, Brown TA. Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol A Biol Sci Med Sci 2009;64:940-948.
35. Mosher DS, Quignon P, Bustamante CD, Sutter NB, Mellersh CS, Parker HG, et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet 2007;3:e79.
36. Schuelke M, Wagner KR, Stolz LE, Hübner C, Riebel T, Komen W, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350:2682-2688. (Pubitemid 38788003)
37. Pavlovičová M, Novotová M, Zahradník I. Structure and composition of tubular aggregates of skeletal muscle fibres. Gen Physiol Biophys 2003;22:425-440. (Pubitemid 38324662)
38. Mendias CL, Bakhurin KI, Faulkner JA. Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci USA 2008;105:388-393.
39. Hamrick MW, Samaddar T, Pennington C, McCormick J. Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J Bone Miner Res 2006;21:477-483. (Pubitemid 43306569)
40. Manceau M, Gros J, Savage K, Thome V, McPherron A, Paterson B, et al. Myostatin promotes the terminal differentiation of embryonic muscle progenitors. Genes Dev 2008;22:668-681. (Pubitemid 351342438)
41. Hamer PW, McGeachie JM, Davies MJ, Grounds MD. Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat 2002;200: 69-79.
42. Kiernan JA. Histological and histochemical methods: theory and practice. Oxford: Butterworth Heinemann; 1999. p 319-320.
43. Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 2005;102: 2519-2524. (Pubitemid 40279409)
44. Holmes JH, Ashmore CR, Robinson DW. Effects of stress on cattle with hereditary muscular hypertrophy. J Anim Sci 1973;36:684-694.
45. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004;2:e294.
46. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, Viereck J, et al. Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 2008;7:159-172. (Pubitemid 351168553)
47. Grobet L, Pirottin D, Farnir F, Poncelet D, Royo LJ, Brouwers B, et al. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis 2003;35:227-238.
48. Welle S, Bhatt K, Pinkert CA, Tawil R, Thornton CA. Muscle growth after postdevelopmental myostatin gene knockout. Am J Physiol Endocrinol Metab 2007;292:E985-E991.
49. Billat VL, Mouisel E, Roblot N, Melki J. Inter- and intrastrain variation in mouse critical running speed. J Appl Physiol 2005;98: 1258-1263.
50. Harber MP, Gallagher PM, Creer AR, Minchev KM, Trappe SW. Single muscle fiber contractile properties during a competitive season in male runners. Am J Physiol Regul Integr Comp Physiol 2004;287: R1124-R1131.
51. Trappe S, Harber M, Creer A, Gallagher P, Slivka D, Minchev K, et al. Single muscle fiber adaptations with marathon training. J Appl Physiol 2006;101:721-727.
52. Nader GA. Concurrent strength and endurance training: from molecules to man. Med Sci Sports Exerc 2006;38:1965-1970.